Categories AlphaGraphs, Retail
Trxade (MEDS) stock soars after a big top-line beat
Trxade's Q2 revenue grows 244% as pandemic drives demand for personal protective equipment
Trxade (NASDAQ: MEDS) on Monday posted second-quarter revenues that more-than-tripled to $6.6 million, primarily driven by higher sales of personal protective equipment (PPE) through its Integra Pharma unit. The top-line was way ahead of the average Wall Street consensus of $2.15 million in revenues.
Meanwhile, the company swung to a loss of $0.07 per share, from a profit of $0.01 per share a year ago, as lower margins on the pandemic-driven products weighed on the bottom-line results. Analysts, were on average, expecting a profit of 1 cent per share.
The big top-line beat sent the stock soaring 35% during after-market hours. The stock has gained 74% in the trailing 12 months.
Trxade, which brings together independent pharmacies under one umbrella through its web-based purchasing platform, was recently uplisted to Nasdaq. The company is now present in all 50 states and is rapidly adding pharmacies to its network.
In the second quarter, the Tampa, Florida-based firm added 325 new independent pharmacies to its network. The company now has approximately 11,725 registered pharmacy members. CEO Suren Ajjarapu said:
“As we move through the second half of 2020, we are better positioned than ever to execute upon our vision of continued growth of the platform, driven by new independent pharmacies, new suppliers and distributors.”
Bonum Health and DelivMeds, Trxade’s telemedical portals, help independent pharmacies offer same-day delivery of drugs to around 15 million patients.
Later today, Trxade is set to hold its first post-earnings conference call.
[irp posts=”64296″]
Prior quarter performance
Most Popular
United Parcel Service (UPS) seems on track to regain lost strength
Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic
IPO Alert: What to look for when Boundless Bio goes public
Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.
Nike (NKE) bets on innovation and partnerships to return to high growth
Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company